Abstract
Background: BACE1 is the rate-limiting enzyme in the synthesis of Aβ from amyloid precursor protein. Results: Human miR-339-5p negatively regulates BACE1 and Aβ in human brain cultures and is reduced in AD specimens. Conclusion: Human miR-339-5p physiologically regulates human BACE1 protein expression and Aβ and is dysregulated in the AD brain. Significance: miR-339-5p represents a novel drug target in AD.
Original language | English |
---|---|
Pages (from-to) | 5184-5198 |
Number of pages | 15 |
Journal | Journal of Biological Chemistry |
Volume | 289 |
Issue number | 8 |
DOIs | |
State | Published - Feb 21 2014 |